Home Cart Sign in  
Chemical Structure| 544417-40-5 Chemical Structure| 544417-40-5

Structure of Capadenoson
CAS No.: 544417-40-5

Chemical Structure| 544417-40-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Capadenoson is an oral active, potent and selective adenosine A1 receptor agonist.

Synonyms: BAY 68-4986

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Capadenoson

CAS No. :544417-40-5
Formula : C25H18ClN5O2S2
M.W : 520.03
SMILES Code : N#CC1=C(C2=CC=C(OCCO)C=C2)C(C#N)=C(SCC3=CSC(C4=CC=C(Cl)C=C4)=N3)N=C1N
Synonyms :
BAY 68-4986
MDL No. :MFCD09954113
InChI Key :CITWCLNVRIKQAF-UHFFFAOYSA-N
Pubchem ID :9936489

Safety of Capadenoson

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Capadenoson

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00568945 Atrial Fibrillation Phase 2 Completed - Germany ... More >> Erfurt, Thüringen, Germany, 99084 Less <<
NCT00518921 Chronic Stable Angina Phase 2 Withdrawn November 2008 Czech Republic ... More >> Brno, Czech Republic, 656 91 Hodonin, Czech Republic, 695 26 Kromeriz, Czech Republic, 767 55 Olomouc, Czech Republic, 775 20 Ostrava, Czech Republic, 708 52 Plzen, Czech Republic, 30599 Praha 13, Czech Republic, 158 00 Praha 6, Czech Republic, 169 02 Hungary Balatonfured, Hungary, 8230 Kecskemet, Hungary, 6000 Miskolc, Hungary, 3526 Pecs, Hungary, 7624 Zalaegerszeg, Hungary, 8900 Israel Hadera, Israel, 38100 Rehovot, Israel, 76100 Safed, Israel, 13100 Italy Mestre, Venezia, Italy, 30174 Genova, Italy, 16132 Pavia, Italy, 27100 Trieste, Italy, 34100 Poland Bialystok, Poland, 15-276 Gdansk, Poland, 80-952 Gdynia, Poland, 81-519 Katowice, Poland, 40-635 Krakow, Poland, 30-501 Legnica, Poland, 59-220 Lodz, Poland, 91-347 Starogard Gdanski, Poland, 83-200 Szczecin, Poland, 70-111 Warszawa, Poland, 03-401 Wroclaw, Poland, 50-420 Wroclaw, Poland, 50-981 Slovakia Bratislava, Slovakia, 811 04 Bratislava, Slovakia, 813 69 Nitra, Slovakia, 949 01 Nove Zamky, Slovakia, 940 34 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.92mL

0.38mL

0.19mL

9.61mL

1.92mL

0.96mL

19.23mL

3.85mL

1.92mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories